Quoin Pharmaceuticals annual current ratio
2017
2019
2020
2021
2022
2023
2024
2025
Quoin Pharmaceuticals Current Ratio Growth & History (QNRX)
Quoin Pharmaceuticals's current ratio was 3.61 for fiscal 2025.
View full Quoin Pharmaceuticals company overviewQuoin Pharmaceuticals annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 3.61 | 0.04 | +1.03% |
| 2024 | 2024-12-31 | 3.57 | 0.42 | +13.29% |
| 2023 | 2023-12-31 | 3.15 | −0.64 | −16.86% |
| 2022 | 2022-12-31 | 3.79 | 2.00 | +111.56% |
| 2021 | 2021-12-31 | 1.79 | 1.29 | +257.79% |
| 2020 | 2020-12-31 | 0.50 | −4.61 | −90.20% |
| 2019 | 2019-12-31 | 5.11 | — | — |
| 2017 | 2017-12-31 | 6.97 | — | — |
Quoin Pharmaceuticals quarterly current ratio
Q4.17
Q2.18
Q4.19
Q4.20
Q2.21
Q4.21
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.76 | −0.20 | −9.99% |
| Q1 2026 | 2026-03-31 | 2.87 | 0.29 | +11.45% |
| Q4 2025 | 2025-12-31 | 3.61 | 0.04 | +1.03% |
| Q3 2025 | 2025-09-30 | 1.04 | −1.98 | −65.47% |
| Q2 2025 | 2025-06-30 | 1.95 | −1.39 | −41.56% |
| Q1 2025 | 2025-03-31 | 2.57 | −1.04 | −28.78% |
| Q4 2024 | 2024-12-31 | 3.57 | 0.42 | +13.29% |
| Q3 2024 | 2024-09-30 | 3.02 | −0.07 | −2.12% |
| Q2 2024 | 2024-06-30 | 3.35 | −0.21 | −5.80% |
| Q1 2024 | 2024-03-31 | 3.61 | −0.56 | −13.49% |
| Q4 2023 | 2023-12-31 | 3.15 | −0.64 | −16.86% |
| Q3 2023 | 2023-09-30 | 3.09 | −1.27 | −29.08% |
| Q2 2023 | 2023-06-30 | 3.55 | 2.59 | +270.35% |
| Q1 2023 | 2023-03-31 | 4.18 | — | — |
| Q4 2022 | 2022-12-31 | 3.79 | 2.00 | +111.56% |
| Q3 2022 | 2022-09-30 | 4.35 | — | — |
| Q2 2022 | 2022-06-30 | 0.96 | −2.05 | −68.16% |
| Q4 2021 | 2021-12-31 | 1.79 | 1.29 | +257.79% |
| Q2 2021 | 2021-06-30 | 3.01 | — | — |
| Q4 2020 | 2020-12-31 | 0.50 | −4.61 | −90.20% |
| Q4 2019 | 2019-12-31 | 5.11 | — | — |
| Q2 2018 | 2018-06-30 | 10.31 | — | — |
| Q4 2017 | 2017-12-31 | 6.97 | — | — |
Quoin Pharmaceuticals current ratio trends
Over the last five fiscal years, Quoin Pharmaceuticals's current ratio increased from 0.50 to 3.61, a change of 3.11. The latest reported quarter, Q2 2026, shows 1.76.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Quoin Pharmaceuticals source filings ↗